|

ALX148 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Evorpacept

Pipeline

Phase 1: 1

Top Sponsors

  • QuantumLeap Healthcare Collaborative1

Indications

  • PR-positive Breast Cancer1
  • Progesterone Receptor-positive Breast Cancer1
  • Estrogen Receptor Positive Tumor1
  • HR Positive1
  • Metastatic1

Birmingham, Alabama1 trial

PRE-I-SPY Phase I/Ib Oncology Platform Program

The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.